⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1043052 | 1.00 | CYP2D6 (0.48) | — | |
| SCHEMBL1093603 | 1.00 | — | — | |
| SCHEMBL13915449 | 1.00 | CYP2D6 (0.48) | — | |
| SCHEMBL19679818 | 0.96 | KMT2A (0.46) | — | |
| SCHEMBL1044668 | 0.96 | KMT2A (0.46) | — | |
| SCHEMBL1045372 | 0.96 | KMT2A (0.46) | — | |
| SCHEMBL577083 | 0.96 | KMT2A (0.46) | — | |
| SCHEMBL19679814 | 0.96 | KMT2A (0.46) | — | |
| SCHEMBL577863 | 0.96 | KMT2A (0.46) | — | |
| Hydrochloric Acid SCHEMBL4751493 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 935 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024101965-A1 | PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE | 에스케이바이오팜 주식회사 | 2024-05-16 | — | — | WO | claimed |
| US-20240101553-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | claimed |
| US-11730720-B2 | ALK5 inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-08-22 | — | — | US | claimed |
| EP-3710439-B1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2023-02-15 | — | — | EP | claimed |
| CN-114929345-A | Substituted pyrazole compounds as TOLL receptor inhibitors | 百时美施贵宝公司 | 2022-08-19 | — | — | CN | claimed |
| EP-3908283-A1 | KRAS G12C INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-11-17 | — | — | EP | claimed |
| EP-3894401-A2 | NAPHTHYRIDINE AND QUINOLINE DERIVATIVES USEFUL AS ALK5 INHIBITORS | Theravance Biopharma R&D IP, LLC (US) | 2021-10-20 | — | — | EP | claimed |
| CN-113195467-A | Naphthyridine and quinoline derivatives useful as ALK5 inhibitors | 施万生物制药研发IP有限责任公司 | 2021-07-30 | — | — | CN | claimed |
| US-20210154178-A1 | ALK5 INHIBITORS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2021-05-27 | — | — | US | claimed |
| US-10952996-B2 | ALK5 inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2021-03-23 | — | — | US | claimed |
| US-8012956-B2 | Tropane compounds | EXELIXIS, INC. (US) | 2011-09-06 | — | — | US | claimed |
| CN-101910168-A | Tropane compounds | EXELIXIS INC | 2010-12-08 | — | — | CN | claimed |
| US-20100126690-A1 | USE OF AMINE BLENDS FOR FOUNDRY SHAPED CORES AND CASTING METALS | ARKEMA FRANCE (FR) | 2010-05-27 | — | — | US | claimed |
| EP-2074120-B1 | TROPANE COMPOUNDS | EXELIXIS INC (US) | 2010-03-03 | — | — | EP | claimed |
| EP-2106310-A1 | USE OF AMINE BLENDS FOR FOUNDRY SHAPED CORES AND CASTING METALS | ARKEMA FRANCE (FR) | 2009-10-07 | — | — | EP | claimed |
| CN-100530545-C | Method for forming organic light-emitting layer | MECHARONICS CO LTD (KR) | 2009-08-19 | — | — | CN | claimed |
| EP-2074120-A1 | TROPANE COMPOUNDS | Exelixis, Inc. (US) | 2009-07-01 | — | — | EP | claimed |
| US-20090163471-A1 | Tropane compounds | EXELIXIS, INC. | 2009-06-25 | — | — | US | claimed |
| WO-2009055077-A1 | TROPANE COMPOUNDS | EXELIXIS, INC. (US) | 2009-04-30 | — | — | WO | claimed |
| WO-2008090161-A1 | USE OF AMINE BLENDS FOR FOUNDRY SHAPED CORES AND CASTING METALS | ARKEMA FRANCE (FR) | 2008-07-31 | — | — | WO | claimed |